PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 23, 2026, 9:15 PM ET

Sponsor Check › Qs Club › Issuer

Glucose Health, Inc.

Corporation · organized in DELAWARE · formed Over five years ago · BENTONVILLE, AR · SEC CIK 1420108

Part of sponsor group: Qs Club (15 issuers, 38 filings) · grouped because: shared people · confidence 82% · Not the same sponsor? Request a correction

14Form D filings
$960,000max total sold reported
10investors (max reported)
2019–2026filing years
8new offerings, last 12 mo

Data last updated: Oct 23, 2026, 5:45 PM ET · Latest filing by this issuer: Oct 19, 2026 · Courts (RECAP) last checked: not yet · SEC enforcement last checked: not yet

Key records

The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.

1. Lawsuits

Not yet searched.

Sources to be searched: CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.

2. Regulatory actions

Not yet searched.

Sources to be searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. State securities regulator actions: not yet searched. · Search queued. Results are added automatically; check back later or follow this page to be notified.

3. Bankruptcies

Not yet searched.

Sources to be searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.

4. Differences between public sources

Coming soon.

What will be compared: what the sponsor says publicly (website, marketing materials, claimed profile) against what public records show — SEC Form D filings, Form ADV adviser registration, and state business records. Every comparison is reviewed by a person before it is published.

No comparisons published yet.

Sources to be compared: sponsor public claims · SEC Form D · SEC Form ADV (IAPD) · state business records · As of Oct 23, 2026, 9:15 PM ET.

5. Money to insiders and sales commissions

0 of 13 offerings report sales commissions; 0 report finder's fees; 2 report proceeds to related persons totalling $72,000. (includes amounts the issuer reported as estimates)

SourceOffering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell it
EDGAR ↗May 3, 2019 D
File 021-338746
$0$0$0None listed
EDGAR ↗May 12, 2020 D
File 021-366749
$0$0$0None listed
EDGAR ↗Jun 19, 2020 D
File 021-369359
$0$0$0None listed
EDGAR ↗Mar 9, 2021 D
File 021-391678
$0$0$0None listed
EDGAR ↗Jan 19, 2024 D/A
File 021-499069
$0$0$0None listed
EDGAR ↗Dec 5, 2025 D
File 021-565982
$0$0$0 (est.)None listed
EDGAR ↗Feb 4, 2026 D
File 021-572404
$0$0$0 (est.)None listed
EDGAR ↗Jul 7, 2026 D
File 021-589791
$0$0$0 (est.)None listed
EDGAR ↗Sep 10, 2026 D
File 021-597074
$0$0$0 (est.)None listed
EDGAR ↗Oct 6, 2026 D
File 021-600098
$0$0$12,000 (est.)
Amount equals value of restricted stock issued to entity owned by director for services rendered to the Issuer
None listed
EDGAR ↗Oct 6, 2026 D
File 021-600102
$0$0$0 (est.)None listed
EDGAR ↗Oct 7, 2026 D
File 021-600381
$0$0$0 (est.)None listed
EDGAR ↗Oct 19, 2026 D
File 021-601719
$0$0$60,000 (est.)
Amount represents aggregate accrued obligation for services rendered satisfied by issuance of restricted shares by Issuer to entity owned by executive officer.
None listed

As reported by the issuer on Form D (Items 12–15), latest filing per offering. "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates.

Offerings (SEC Form D)

Each filing as reported by the issuer. Open a row for the full plain-English detail.

Oct 19, 2026 D Other Health Care — $60,000 sold of $60,000 · 1 investors EDGAR ↗
FilingForm D filed Oct 19, 2026
SEC file no. 021-601719 · accession 0001420108-26-000007
Raise progress$60,000 sold of $60,000 offered (100%) · $0 remaining
Amount represents accrued unpaid obligation for services rendered satisfied by issuance of restricted shares by Issuer to recipient.
Filing timingDate of first sale: Oct 5, 2026 · Form D filed: Oct 19, 2026 (14 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale19 days (0.1 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year.
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors1 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed
Minimum investment accepted$0
Securities offeredEquity
Industry / issuer sizeOther Health Care · revenue range: $1 - $1,000,000
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $60,000 (est.)
Amount represents aggregate accrued obligation for services rendered satisfied by issuance of restricted shares by Issuer to entity owned by executive officer.
Signed byJohn Duffy, CEO (Oct 19, 2026)
Market contextMinimum investment: $0. Typical range for similar offerings: $10,000–$54,310.
Offering size: $60,000. Typical range: $829,831–$9,999,998.
Investors: 1. Typical range: 2–15.
"Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score.
SourceThis filing on SEC EDGAR ↗ · retrieved from the EDGAR daily index
Oct 7, 2026 D Other Health Care — $172,500 sold of $172,500 · 1 investors EDGAR ↗
FilingForm D filed Oct 7, 2026
SEC file no. 021-600381 · accession 0001420108-26-000006
Raise progress$172,500 sold of $172,500 offered (100%) · $0 remaining
Amount represents value of additional restricted shares issued to recipient for services rendered to the Issuer.
Filing timingDate of first sale: Sep 22, 2026 · Form D filed: Oct 7, 2026 (15 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale32 days (0.1 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year.
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors1 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed
Minimum investment accepted$0
Securities offeredEquity
Industry / issuer sizeOther Health Care · revenue range: $1 - $1,000,000
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 (est.)
Signed byJohn Duffy, CEO (Oct 7, 2026)
Market contextMinimum investment: $0. Typical range for similar offerings: $10,000–$54,310.
Offering size: $172,500. Typical range: $829,831–$9,999,998.
Investors: 1. Typical range: 2–15.
"Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score.
SourceThis filing on SEC EDGAR ↗ · retrieved from the EDGAR daily index
Oct 6, 2026 D Other Health Care — $30,000 sold of $30,000 · 1 investors EDGAR ↗
FilingForm D filed Oct 6, 2026
SEC file no. 021-600102 · accession 0001420108-26-000005
Raise progress$30,000 sold of $30,000 offered (100%) · $0 remaining
Amount represents value of restricted stock issued to recipient for services rendered to the Issuer.
Filing timingDate of first sale: Jun 3, 2026 · Form D filed: Oct 6, 2026 (125 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale143 days (0.4 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year.
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors1 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed
Minimum investment accepted$0
Securities offeredEquity
Industry / issuer sizeOther Health Care · revenue range: $1 - $1,000,000
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 (est.)
Signed byJohn Duffy, CEO (Oct 6, 2026)
Market contextMinimum investment: $0. Typical range for similar offerings: $10,000–$54,310.
Offering size: $30,000. Typical range: $829,831–$9,999,998.
Investors: 1. Typical range: 2–15.
"Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score.
SourceThis filing on SEC EDGAR ↗ · retrieved from the EDGAR daily index
Oct 6, 2026 D Other Health Care — $12,000 sold of $12,000 · 1 investors EDGAR ↗
FilingForm D filed Oct 6, 2026
SEC file no. 021-600098 · accession 0001420108-26-000004
Raise progress$12,000 sold of $12,000 offered (100%) · $0 remaining
Amount represents value of restricted shares issued for services rendered by recipient to Issuer
Filing timingDate of first sale: Aug 7, 2026 · Form D filed: Oct 6, 2026 (60 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale78 days (0.2 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year.
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors1 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed
Minimum investment accepted$0
Securities offeredEquity
Industry / issuer sizeOther Health Care · revenue range: $1 - $1,000,000
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $12,000 (est.)
Amount equals value of restricted stock issued to entity owned by director for services rendered to the Issuer
Signed byJohn Duffy, CEO (Oct 6, 2026)
Market contextMinimum investment: $0. Typical range for similar offerings: $10,000–$54,310.
Offering size: $12,000. Typical range: $829,831–$9,999,998.
Investors: 1. Typical range: 2–15.
"Similar" = Other Health Care offerings claiming 506(b) filed in the last 5 years (4,189 filings); ranges are the middle half (25th–75th percentile). No ranking or score.
SourceThis filing on SEC EDGAR ↗ · retrieved from the EDGAR daily index
Sep 10, 2026 D Manufacturing — $10,000 sold of $30,000 · 1 investors EDGAR ↗
FilingForm D filed Sep 10, 2026
SEC file no. 021-597074 · accession 0001420108-26-000003
Raise progress$10,000 sold of $30,000 offered (33%) · $20,000 remaining
Filing timingDate of first sale: Aug 28, 2026 · Form D filed: Sep 10, 2026 (13 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale57 days (0.2 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year.
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors1 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed
Minimum investment accepted$10,000
Securities offeredEquity
Industry / issuer sizeManufacturing · revenue range: $1 - $1,000,000
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 (est.)
Signed byJohn Duffy, CEO (Sep 10, 2026)
Market contextMinimum investment: $10,000. Typical range for similar offerings: $10,000–$60,000.
Offering size: $30,000. Typical range: $1,000,000–$7,247,539.
Investors: 1. Typical range: 2–13.
"Similar" = Manufacturing offerings claiming 506(b) filed in the last 5 years (1,339 filings); ranges are the middle half (25th–75th percentile). No ranking or score.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set
Jul 7, 2026 D Manufacturing — $60,000 sold of $120,000 · 1 investors EDGAR ↗
FilingForm D filed Jul 7, 2026
SEC file no. 021-589791 · accession 0001420108-26-000002
Raise progress$60,000 sold of $120,000 offered (50%) · $60,000 remaining
Filing timingDate of first sale: Jun 25, 2026 · Form D filed: Jul 7, 2026 (12 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale121 days (0.3 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year.
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors1 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed
Minimum investment accepted$60,000
Securities offeredEquity; Option, warrant or other right to acquire; Other: Investment Units. Each Unit consists of one share of common stock and warrant to purchase one share of common stock 0ver 5 year term at $0.60 per shares
Industry / issuer sizeManufacturing · revenue range: $1 - $1,000,000
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 (est.)
Signed byMark Schaftlein, CEO (Jul 7, 2026)
Market contextMinimum investment: $60,000. Typical range for similar offerings: $10,000–$60,000.
Offering size: $120,000. Typical range: $1,000,000–$7,247,539.
Investors: 1. Typical range: 2–13.
"Similar" = Manufacturing offerings claiming 506(b) filed in the last 5 years (1,339 filings); ranges are the middle half (25th–75th percentile). No ranking or score.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set
Feb 4, 2026 D Manufacturing — $100,000 sold of $100,000 · 1 investors EDGAR ↗
FilingForm D filed Feb 4, 2026
SEC file no. 021-572404 · accession 0001420108-26-000001
Raise progress$100,000 sold of $100,000 offered (100%) · $0 remaining
Filing timingDate of first sale: Jan 27, 2026 · Form D filed: Feb 4, 2026 (8 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale270 days (0.7 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year.
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors1 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed
Minimum investment accepted$100,000
Securities offeredEquity; Option, warrant or other right to acquire; Other: Investment Units - Each Unit consists of one share of common stock and warrant to purchase one share of common stock over 3 year term at $0.35 per share
Industry / issuer sizeManufacturing · revenue range: $1 - $1,000,000
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 (est.)
Signed byMark Schaftlein, CEO (Feb 4, 2026)
Market contextMinimum investment: $100,000. Typical range for similar offerings: $10,000–$60,000.
Offering size: $100,000. Typical range: $1,000,000–$7,247,539.
Investors: 1. Typical range: 2–13.
"Similar" = Manufacturing offerings claiming 506(b) filed in the last 5 years (1,339 filings); ranges are the middle half (25th–75th percentile). No ranking or score.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set
Dec 5, 2025 D Manufacturing — $20,000 sold of $20,000 · 2 investors EDGAR ↗
FilingForm D filed Dec 5, 2025
SEC file no. 021-565982 · accession 0001420108-25-000002
Raise progress$20,000 sold of $20,000 offered (100%) · $0 remaining
Filing timingDate of first sale: Nov 24, 2025 · Form D filed: Dec 5, 2025 (11 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale334 days (0.9 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year.
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors2 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed
Minimum investment accepted$10,000
Securities offeredEquity; Option, warrant or other right to acquire; Other: Investment Units with each Unit consisting of one share of common stock and warrant to purchase one share of common stock
Industry / issuer sizeManufacturing · revenue range: $1 - $1,000,000
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 (est.)
Signed byMark Schaftlein, CEO (Dec 5, 2025)
Market contextMinimum investment: $10,000. Typical range for similar offerings: $10,000–$60,000.
Offering size: $20,000. Typical range: $1,000,000–$7,247,539.
Investors: 2. Typical range: 2–13.
"Similar" = Manufacturing offerings claiming 506(b) filed in the last 5 years (1,339 filings); ranges are the middle half (25th–75th percentile). No ranking or score.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set
Jan 19, 2024 D/A Manufacturing — $290,000 sold of $290,000 · 5 investors EDGAR ↗
FilingForm D/A (amendment) filed Jan 19, 2024 · amends 0001477932-23-009018 ↗
SEC file no. 021-499069 · accession 0001477932-24-000270
Raise progress$290,000 sold of $290,000 offered (100%) · $0 remaining
Filing timingDate of first sale: Dec 4, 2023 · Form D filed: Jan 19, 2024 (46 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale1,055 days (2.9 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year.
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors5 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed
Minimum investment accepted$15,000
Securities offeredEquity
Industry / issuer sizeManufacturing · revenue range: $1 - $1,000,000
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0
Signed byMurray Fleming, CEO, Director (Jan 18, 2024)
Changes vs prior filingtotal sold: $275,000 → $290,000
total offering: $275,000 → $290,000
investors: 4 → 5
minimum investment: $25,000 → $15,000
Compared with the D filed Dec 7, 2023 (EDGAR ↗). Amendment history as filed; no conclusion is drawn.
Market contextMinimum investment: $15,000. Typical range for similar offerings: $10,000–$60,000.
Offering size: $290,000. Typical range: $1,000,000–$7,247,539.
Investors: 5. Typical range: 2–13.
"Similar" = Manufacturing offerings claiming 506(b) filed in the last 5 years (1,339 filings); ranges are the middle half (25th–75th percentile). No ranking or score.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set
Dec 7, 2023 D Manufacturing — $275,000 sold of $275,000 · 4 investors EDGAR ↗
FilingForm D filed Dec 7, 2023
SEC file no. 021-499069 · accession 0001477932-23-009018
Raise progress$275,000 sold of $275,000 offered (100%) · $0 remaining
Filing timingDate of first sale: Dec 4, 2023 · Form D filed: Dec 7, 2023 (3 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale1,055 days (2.9 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year.
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors4 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed
Minimum investment accepted$25,000
Securities offeredEquity
Industry / issuer sizeManufacturing · revenue range: $1 - $1,000,000
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0
Signed byMurray Fleming, CEO, Director (Dec 7, 2023)
Market contextMinimum investment: $25,000. Typical range for similar offerings: $10,000–$60,000.
Offering size: $275,000. Typical range: $1,000,000–$7,247,539.
Investors: 4. Typical range: 2–13.
"Similar" = Manufacturing offerings claiming 506(b) filed in the last 5 years (1,339 filings); ranges are the middle half (25th–75th percentile). No ranking or score.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set
Mar 9, 2021 D Manufacturing — $960,000 sold of $960,000 · 10 investors EDGAR ↗
FilingForm D filed Mar 9, 2021
SEC file no. 021-391678 · accession 0001477932-21-001334
Raise progress$960,000 sold of $960,000 offered (100%) · $0 remaining
Filing timingDate of first sale: Feb 11, 2021 · Form D filed: Mar 9, 2021 (26 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale2,081 days (5.7 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year.
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors10 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed
Minimum investment accepted$25,000
Securities offeredEquity
Industry / issuer sizeManufacturing · revenue range: $1 - $1,000,000
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0
Signed byMurray Fleming, CEO (Mar 9, 2021)
Market contextMinimum investment: $25,000. Typical range for similar offerings: $10,000–$60,000.
Offering size: $960,000. Typical range: $1,000,000–$7,247,539.
Investors: 10. Typical range: 2–13.
"Similar" = Manufacturing offerings claiming 506(b) filed in the last 5 years (1,339 filings); ranges are the middle half (25th–75th percentile). No ranking or score.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set
Jun 19, 2020 D Manufacturing — $300,000 sold of $300,000 · 8 investors EDGAR ↗
FilingForm D filed Jun 19, 2020
SEC file no. 021-369359 · accession 0001477932-20-003466
Raise progress$300,000 sold of $300,000 offered (100%) · $0 remaining
Filing timingDate of first sale: Jun 17, 2020 · Form D filed: Jun 19, 2020 (2 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale2,320 days (6.4 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year.
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors8 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed
Minimum investment accepted$0
Securities offeredEquity
Industry / issuer sizeManufacturing · revenue range: $1 - $1,000,000
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0
Signed byMurray Fleming, CEO (Jun 19, 2020)
Market contextMinimum investment: $0. Typical range for similar offerings: $10,000–$60,000.
Offering size: $300,000. Typical range: $1,000,000–$7,247,539.
Investors: 8. Typical range: 2–13.
"Similar" = Manufacturing offerings claiming 506(b) filed in the last 5 years (1,339 filings); ranges are the middle half (25th–75th percentile). No ranking or score.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set
May 12, 2020 D Manufacturing — $65,000 sold of $65,000 · 4 investors EDGAR ↗
FilingForm D filed May 12, 2020
SEC file no. 021-366749 · accession 0001477932-20-002548
Raise progress$65,000 sold of $65,000 offered (100%) · $0 remaining
Filing timingDate of first sale: May 1, 2020 · Form D filed: May 12, 2020 (11 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale2,367 days (6.5 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year.
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors4 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed
Minimum investment accepted$0
Securities offeredEquity
Industry / issuer sizeManufacturing · revenue range: $1 - $1,000,000
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0
Signed byMurray Fleming, CEO (May 12, 2020)
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set
May 3, 2019 D Manufacturing — $460,000 sold of $460,000 · 4 investors EDGAR ↗
FilingForm D filed May 3, 2019
SEC file no. 021-338746 · accession 0001477932-19-002298
Raise progress$460,000 sold of $460,000 offered (100%) · $0 remaining
Filing timingDate of first sale: May 1, 2019 · Form D filed: May 3, 2019 (2 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale2,733 days (7.5 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year.
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors4 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed
Minimum investment accepted$0
Securities offeredEquity
Industry / issuer sizeManufacturing · revenue range: $1 - $1,000,000
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0
Signed byMurray Fleming, CEO (May 2, 2019)
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set

All Form D filings for this CIK on SEC EDGAR ↗. History: 8 new offerings in the last 12 months · most recent filing Oct 19, 2026 · industry as reported over time: Manufacturing → Other Health Care.

Key people (related persons as listed on Form D)

NameRelationshipAddress stateOn filingsAlso listed on
Christopher JemapeteDirectorARSep 10, 2026 → Oct 19, 2026—
Edmund BurkeDirectorARDec 5, 2025 → Oct 19, 2026—
John DuffyExecutive Officer, DirectorARSep 10, 2026 → Oct 19, 2026—
Marc HatchExecutive Officer
Chief Operating Officer and Chief Financial Officer of Issuer
ARDec 5, 2025 → Oct 19, 2026—
Mark SchaftleinDirector
CEO and Director of Issuer
ARDec 5, 2025 → Oct 19, 2026—
marc HatchExecutive Officer
Chief Operating Officer and Chief Financial Officer of Issuer
ARSep 10, 2026—
Chris JemapeteDirectorARDec 5, 2025 → Jul 7, 2026—
Edmunc burkeDirectorARFeb 4, 2026—
Fleming FlemingDirectorARDec 5, 2025—
Murray FlemingExecutive Officer, DirectorARMay 3, 2019 → Jan 19, 2024—
Gerry DavidDirectorARJun 19, 2020 → Mar 9, 20211 other issuer
Hal KravitzDirectorARJun 19, 2020 → Mar 9, 20211 other issuer
John FieldlyDirectorARJun 19, 2020 → Mar 9, 20211 other issuer

Executive officers, directors and promoters as self-reported by the issuer. Licensed persons: FINRA BrokerCheck ↗ · SEC IAPD ↗.

Connections

Other issuers listing the same people:

Shared address: this business address appears on filings for 2 other issuers. Stated as a count only — many addresses are shared office buildings or registered agents.

Adviser registration (Form ADV)

Not yet searched. Sources to be searched: SEC Investment Adviser Public Disclosure (IAPD) firm search — registered and exempt reporting advisers · Search queued. Results are added automatically; check back later.

Public profiles

Not yet collected. We store official links only (company website, verified via a profile claim) and the earliest archived date of the website; never personal or family accounts.

Export this report as PDF (all source links + data timestamp; members)

Change history

No corrections have been requested for this page.

Facts from public records only, each linked to its source. No ratings, no opinions. Request a correction · Claim this profile · Facts policy

Email me the full report

The complete public-record profile for Glucose Health, Inc., plus the weekly new-filings list.

What do you want to do?

Only "Connect me" shares your details — with this sponsor, at a flat price we charge them, never tied to whether you invest. "Just researching" shares nothing.

Request a correction

Free. Tell us what's wrong and, if you can, where the correct public record is. Every request is logged with its status (received → under review → fixed / confirmed with source).

Sponsor response

Sponsors may add a sourced explanation next to any fact on this page. Reviewed before publishing; never edits the public record.

Claim this profile (sponsors)

Free. Get the "Claimed by sponsor" chip and a verified contact for corrections. Claiming never changes the public-record section.